Q4 earnings today were mixed. Revenues were a record at $21.3 million, but they managed to lose $5.5 million. Endometriosis is progressing and hopefully gets approved later this year. They maybe we have a huge winner here. My valuation rose to $7.64.

https://finance.yahoo.com/news/edap-reports-fourth-quarter-full-110000921.html